# Antares Pharma, Inc – FDA Inspection, Jan 21, 2016

Source: https://www.keypedia.com/records/fda_inspections/antares-pharma-inc/80b98457-90a0-4a7e-b804-62a14a623d99
Source feed: FDA_Inspections

> FDA inspection 963398 of Antares Pharma, Inc, January 21, 2016. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 963398
- Company Name: Antares Pharma, Inc
- Inspection Date: 2016-01-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 0

## Related Documents

- [FDA Inspection 1257757 - 2025-01-16](https://www.keypedia.com/records/fda_inspections/antares-pharma-inc/a7937fcd-171d-4503-8be5-3396181711b9)
- [FDA Inspection 1073695 - 2018-12-04](https://www.keypedia.com/records/fda_inspections/antares-pharma-inc/cf3dc7da-f90a-4788-bcc7-9ec40e1ebdce)
- FDA Inspection 798055 - 2012-09-06
- FDA Inspection 596396 - 2009-07-14

Company: https://www.keypedia.com/companies/antares-pharma-inc/27f8256c-c1d6-4d41-b448-7fcac44937dc

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
